CN-122005360-A - Cosmetic kit comprising a mixed cosmetic composition with a character transformed from a liquid-phase astringent form to a cream form

Abstract

The present disclosure relates to a cosmetic kit containing a hybrid cosmetic composition with a trait converted from a liquid-phase, astringent form to a cream form. In particular, the cosmetic kit according to the present disclosure can transform the character from the liquid-phase astringent form to the cream form in a short time without applying a significant physical force, thereby stably forming and maintaining the cream form even in a low temperature or small force applied environment.

Inventors

• Ha aewan

Assignees

• 株式会社爱茉莉太平洋

Dates

Publication Date

20260512

Application Date

20250911

Priority Date

20241111

Claims (16)

1. 1. A cosmetic kit, comprising: a first composition in the form of a nanoemulsion of a liquid phase comprising wax and oil, and A second agent composition which is a liquid phase containing water and at least one of a salt and a pH-lowering agent, The first and second dose compositions are separated from each other.
2. 2. The cosmetic kit of claim 1, wherein, When the first and second compositions are mixed, the character of the mixed composition is converted from a liquid-phase, astringent form to a cream form.
3. 3. The cosmetic kit of claim 2, wherein, The hardness of the mixed composition in the form of a cream is 10 to 70gf/cm 2 .
4. 4. The cosmetic kit of claim 1, wherein, The wax is contained in an amount of 5 to 20% by weight relative to the total weight of the first dose composition.
5. 5. The cosmetic kit of claim 1, wherein, The oil is an ester oil.
6. 6. The cosmetic kit of claim 1, wherein, The oil is present in an amount of 3 to 10% by weight relative to the total weight of the first dose composition.
7. 7. The cosmetic kit of claim 1, wherein, The first and second dose compositions are mixed in a weight ratio of 15 to 25:1.
8. 8. The cosmetic kit of claim 1, wherein, The salt is more than one selected from sodium chloride and magnesium sulfate.
9. 9. The cosmetic kit of claim 1, wherein, The pH reducing agent is at least one selected from polyhydroxyacids and alpha-hydroxyacids.
10. 10. The cosmetic kit of claim 9, wherein, The polyhydroxyacid is gluconolactone.
11. 11. The cosmetic kit of claim 9, wherein, The alpha-hydroxy acid is more than one selected from glycolic acid, lactic acid and mandelic acid.
12. 12. The cosmetic kit of claim 1, wherein, The first dose of composition relative to the total weight of the first and second dose of compositions, Containing an amount of 90 to 97% by weight.
13. 13. The cosmetic kit of claim 1, wherein, The second dose of composition relative to the total weight of the first and second dose of compositions, Containing an amount of 3 to 10% by weight.
14. 14. A skin-beautifying method as a skin-beautifying method using the cosmetic kit according to any one of claims 1 to 13, the method comprising: A step of applying a first dose of the composition in the cosmetic kit according to any one of claims 1 to 13 to the skin and then applying a second dose of the composition to the skin, thereby mixing by rubbing; or (b) A step of mixing the first and second compositions in the cosmetic kit of any one of claims 1 to 13 and then applying to the skin.
15. 15. The method of claim 14, wherein, When the first and second compositions are mixed, the character of the mixed composition is converted from a liquid-phase, astringent form to a cream form.
16. 16. The method of claim 14, wherein, The first and second dose compositions are mixed in a weight ratio of 15 to 25:1.

Description

Cosmetic kit comprising a mixed cosmetic composition with a character transformed from a liquid-phase astringent form to a cream form Technical Field The present disclosure relates to a cosmetic kit containing a hybrid cosmetic composition with a trait converted from a liquid-phase, astringent form to a cream form. Background In general, a liquid cosmetic composition has a disadvantage in that it immediately flows down when applied to the face or skin, so that it is inconvenient to use, and a solid cosmetic composition is used in the form of a paste (balm), so that it needs to be scooped up by hand to be applied to the face or skin. As described above, when a solid cosmetic composition is scooped and applied by hand, hygienic problems may be caused and stability of the dosage form may be affected. In order to overcome the limitations of the formulation, in the case of a cosmetic composition which remains in a solid state at a low temperature and changes phase to a liquid phase form after a predetermined time has elapsed at a skin temperature of a human body, as in the prior art, it has a disadvantage that it is converted to a liquid phase form at a skin temperature of a human body and thus it is still dropped when applied to a face or skin, and it also has an inconvenience in storage that it is necessary to cool before application. In addition, the conventional cosmetic composition which changes phase to a solid form upon rubbing after being applied to the skin has a limitation in that it is required to apply a certain level of force more than a plurality of times to perform rubbing so as to change the phase to a solid form and is formed in a slightly diluted form compared with a general cream form. Disclosure of Invention Technical problem to be solved The object of the present disclosure is to provide a cosmetic kit that can convert a character from a liquid-phase cosmetic water form to a cream form in a short time without applying a significant physical force, thereby stably forming and maintaining a cream form even in a low-temperature or small-force applied environment. Means for solving the problems To achieve the object, an embodiment of the present invention provides a cosmetic kit including a first dose composition in the form of a nanoemulsion of a liquid phase containing wax and oil, and a second dose composition in the form of a liquid phase containing water and one or more of a salt and a pH-lowering agent, the first and second dose compositions being separated from each other. Effects of the invention The cosmetic kit according to the present disclosure can convert the character from the liquid-phase astringent form to the cream form in a short time without applying a significant physical force, thereby stably forming and maintaining the cream form even in a low temperature or small force application environment. Drawings Fig. 1 is a photograph of a first dose of the composition according to an embodiment of the present invention (left side) and a mixed composition of two drops of the second dose of the composition to the first dose of the composition (right side). Fig. 2 is a photograph of a state in which a first dose of the composition (left side) and a mixed composition (right side) of two drops of the second dose of the composition to the first dose of the composition are each kneaded five times according to an embodiment of the present invention. Fig. 3a to 3c are photographs of a state immediately after the first dose of the composition is dropped on the back of the hand (fig. 3 a), a state of being rubbed 5 times (fig. 3 b), and a state of being rubbed 20 times (fig. 3 c) according to an embodiment of the present invention. Fig. 4a to 4d are photographs of a state immediately after the first dose of the composition is dropped on the back of the hand (fig. 4 a), a state of mixing the composition immediately after the second dose of the composition is dropped to the first dose (fig. 4 b), a state of kneading the mixture composition 5 times (fig. 4 c), and a state of kneading the mixture composition 10 times (fig. 4 d), according to an embodiment of the present invention. Detailed Description The present invention will be described in detail below. In one aspect, the present invention may be directed to a cosmetic kit comprising a first dose of a composition in the form of a liquid nanoemulsion and a second dose of a composition in the liquid phase. In one embodiment, the first and second dose compositions may be separate from each other. In one embodiment, the first and second compositions may be mixed immediately prior to use. In one embodiment, the first and second compositions may be mixed such that the character of the mixed composition is converted from a liquid-phase astringent form to a cream form. In one embodiment, the viscosity of the liquid phase first dose composition may be 100 to 1000cps. Specifically, the viscosity of the first agent composition of the liquid phase may be